127 related articles for article (PubMed ID: 3660520)
1. Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.
Zincke H; Utz DC; Thulé PM; Taylor WF
Urology; 1987 Oct; 30(4):307-15. PubMed ID: 3660520
[TBL] [Abstract][Full Text] [Related]
2. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
Zincke H; Utz DC; Taylor WF
J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
[TBL] [Abstract][Full Text] [Related]
3. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for stage C or D1 adenocarcinoma of the prostate: possible beneficial effect of adjuvant treatment.
Zincke H
NCI Monogr; 1988; (7):109-15. PubMed ID: 3173496
[TBL] [Abstract][Full Text] [Related]
4. Observations on surgical management of carcinoma of prostate with limited nodal metastases.
Zincke H; Utz DC
Urology; 1984 Aug; 24(2):137-45. PubMed ID: 6464250
[TBL] [Abstract][Full Text] [Related]
5. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.
Zincke H
Urology; 1989 May; 33(5 Suppl):27-36. PubMed ID: 2775377
[TBL] [Abstract][Full Text] [Related]
6. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for Stage C adenocarcinoma of prostate.
Zincke H; Utz DC; Benson RC; Patterson DE
Urology; 1984 Dec; 24(6):532-9. PubMed ID: 6506391
[TBL] [Abstract][Full Text] [Related]
7. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy.
Cheng CW; Bergstralh EJ; Zincke H
Cancer; 1993 Feb; 71(3 Suppl):996-1004. PubMed ID: 7679047
[TBL] [Abstract][Full Text] [Related]
8. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup.
Myers RP; Larson-Keller JJ; Bergstralh EJ; Zincke H; Oesterling JE; Lieber MM
J Urol; 1992 Mar; 147(3 Pt 2):910-5. PubMed ID: 1538495
[TBL] [Abstract][Full Text] [Related]
9. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiation, chemotherapy, and androgen deprivation therapy for pathologic stage D1 adenocarcinoma of the prostate.
Freeman JA; Lieskovsky G; Grossfeld G; Esrig D; Stein JP; Cook DW; Petrovich Z; Chen SC; Groshen S; Skinner DG
Urology; 1994 Nov; 44(5):719-25. PubMed ID: 7526528
[TBL] [Abstract][Full Text] [Related]
11. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
Elfving P; Lundgren R
Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
[TBL] [Abstract][Full Text] [Related]
12. Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for adenocarcinoma of prostate with regional lymph node involvement.
Zincke H; Utz DC; Myers RP; Farrow GM; Patterson DE; Furlow WL
Urology; 1982 Mar; 19(3):238-47. PubMed ID: 7064249
[TBL] [Abstract][Full Text] [Related]
13. Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PcN0) prostate cancer from 1976 to 1989: intermediate findings.
Freeman JA; Lieskovsky G; Cook DW; Petrovich Z; Chen S; Groshen S; Skinner DG
J Urol; 1993 May; 149(5):1029-34. PubMed ID: 8483203
[TBL] [Abstract][Full Text] [Related]
14. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
[TBL] [Abstract][Full Text] [Related]
15. Early endocrine therapy versus radical prostatectomy combined with early endocrine therapy for stage D1 prostate cancer.
Schmeller N; Lubos W
Br J Urol; 1997 Feb; 79(2):226-34. PubMed ID: 9052475
[TBL] [Abstract][Full Text] [Related]
16. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
Cadeddu JA; Partin AW; Epstein JI; Walsh PC
Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297
[TBL] [Abstract][Full Text] [Related]
17. Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone.
Frohmüller HG; Theiss M; Manseck A; Wirth MP
Eur Urol; 1995; 27(3):202-6. PubMed ID: 7601183
[TBL] [Abstract][Full Text] [Related]
18. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H
J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874
[TBL] [Abstract][Full Text] [Related]
19. Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
Utz DC
Urology; 1984 Nov; 24(5 Suppl):4-11. PubMed ID: 6495469
[TBL] [Abstract][Full Text] [Related]
20. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
Zincke H
Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
[No Abstract] [Full Text] [Related]
[Next] [New Search]
